Ionis Pharmaceuticals IONS Intersegment Elimination — Operating Income
Discontinued — last reported Q1 '18
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Ionis Pharmaceuticals’s 10-Q, filed May 7, 2018, on SEC EDGAR. View the filing →
Questions, answered.
- What does intersegment elimination — operating income mean?
- The adjustment to remove internal operating profits or losses during consolidation.
- How do you interpret intersegment elimination — operating income?
- Fluctuations indicate changes in the internal pricing or volume of services provided between business units.
- How does intersegment elimination — operating income compare across companies?
- Common in multi-segment firms to reconcile internal segment reporting to consolidated GAAP results.